Location History:
- Fukushima, JP (2013)
- Iwaki, JP (2013 - 2014)
- Tokyo, JP (2018)
Company Filing History:
Years Active: 2013-2018
Title: Mieko Kuwahara: Innovator in Therapeutic Agents
Introduction
Mieko Kuwahara is a prominent inventor based in Iwaki, Japan. She has made significant contributions to the field of medical therapeutics, particularly in the development of innovative adsorbents for treating renal and liver diseases. With a total of 5 patents to her name, Kuwahara's work is recognized for its potential impact on healthcare.
Latest Patents
Kuwahara's latest patents include groundbreaking inventions such as an orally administered adsorbent and therapeutic agents for renal and liver diseases. One of her notable inventions is a spherical activated carbon that exhibits excellent adsorption ability for uremic substances in the body, specifically targeting -aminoisobutyric acid. This orally administered adsorbent comprises spherical activated carbon containing not less than 0.5 wt % of nitrogen atoms, with a specific surface area determined by the Brunauer-Emmett-Teller (BET) method ranging from 700 m/g to 3000 m, and an average particle size between 0.01 to 1 mm. Another significant patent involves a surface-modified spherical activated carbon designed for oral administration, which has a high adsorbability and is capable of adsorbing a large amount of toxins during a retention period in the intestine, thereby remarkably reducing urinary protein excretion.
Career Highlights
Kuwahara is currently associated with Kureha Corporation, where she continues to innovate and develop new therapeutic solutions. Her work has garnered attention for its scientific rigor and practical applications in medicine.
Collaborations
Some of her notable coworkers include Takashi Wakahoi and Naohiro Sonobe, who have collaborated with her on various projects, contributing to the advancement of their shared goals in medical research.
Conclusion
Mieko Kuwahara's contributions to the field of therapeutic agents highlight her innovative spirit and dedication to improving healthcare outcomes. Her patents reflect a commitment to addressing critical health challenges through scientific innovation.